| Literature DB >> 22140460 |
Duk Kyung Kim1, Hyun Lillehoj, Wongi Min, Chul Hong Kim, Myeong Seon Park, Yeong Ho Hong, Erik P Lillehoj.
Abstract
Relative expression levels of immune- and non-immune-related mRNAs in chicken intestinal intraepithelial lymphocytes experimentally infected with Eimeria acervulina, E. maxima, or E. tenella were measured using a 10K cDNA microarray. Based on a cutoff of >2.0-fold differential expression compared with uninfected controls, relatively equal numbers of transcripts were altered by the three Eimeria infections at 1, 2, and 3 days post-primary infection. By contrast, E. tenella elicited the greatest number of altered transcripts at 4, 5, and 6 days post-primary infection, and at all time points following secondary infection. When analyzed on the basis of up- or down-regulated transcript levels over the entire 6 day infection periods, approximately equal numbers of up-regulated transcripts were detected following E. tenella primary (1,469) and secondary (1,459) infections, with a greater number of down-regulated mRNAs following secondary (1,063) vs. primary (890) infection. On the contrary, relatively few mRNA were modulated following primary infection with E. acervulina (35 up, 160 down) or E. maxima (65 up, 148 down) compared with secondary infection (E. acervulina, 1,142 up, 1,289 down; E. maxima, 368 up, 1,349 down). With all three coccidia, biological pathway analysis identified the altered transcripts as belonging to the categories of "Disease and Disorder" and "Physiological System Development and Function". Sixteen intracellular signaling pathways were identified from the differentially expressed transcripts following Eimeria infection, with the greatest significance observed following E. acervulina infection. Taken together, this new information will expand our understanding of host-pathogen interactions in avian coccidiosis and contribute to the development of novel disease control strategies.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22140460 PMCID: PMC3225369 DOI: 10.1371/journal.pone.0027712
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers used for quantitative RT-PCR.
| Symbol | Gene Name | Forward Primer (5′→3′) | Reverse Primer (5′→3′) | GenBank Accession No. |
| ADA | Adenosine deaminase |
|
| NM_001006290.1 |
| BECN1 | Beclin 1, autophagy related |
|
| NM_001006332.1 |
| CCL20 | Chemokine (C-C motif) ligand 20 |
|
| NM_204438.1 |
| CD8A | CD8α molecule |
|
| NM_205235.1 |
| TLR4 | Toll-like receptor 4 |
|
| NM_001030693.1 |
| IL-6 | Interleukin-6 |
|
| AJ309540 |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
|
| K01458 |
Figure 1Comparison of the number of intestinal lymphocyte transcripts with <2.0-fold altered levels following primary (1st) and secondary (2nd) infections by E. acervulina (EA), E. maxima (EM), or E. tenella (ET) compared with uninfected controls (P<0.05).
Figure 2The effects of primary (1st) and secondary (2nd) infections by E. acervulina (EA), E. maxima (EM), or E. tenella (ET) compared with uninfected controls (P<0.0005) on the intestinal lymphocyte transcripts.
(A) The number of transcripts differentially expressed and (B) the number of the overlapping transcripts differentially expressed following 1st and 2nd infections by EA, EM, or ET.
Figure 3Comparison of the number of intestinal lymphocyte transcripts differently expressed when comparing primary (1st) and secondary (2nd) infections by E. acervulina, E. maxima, or E. tenella (P<0.0005).
Figure 4Comparison of the number of intestinal lymphocyte transcripts differentially expressed at 1–3 DPI vs. 4–6 DPI following primary (1st) and secondary (2nd) infections by E. acervulina (EA), E. maxima (EM), or E. tenella (ET).
Comparison between microarray analysis and quantitative RT-PCR.
| Gene Symbol |
| Infection | Microarray | qRT-PCR |
| ADA |
| 2nd | 2.2 | 2.2 |
|
| 1st | −7.5 | −6.7 | |
|
| 2nd | −7.6 | −10.3 | |
| BECN1 |
| 2nd | 2.3 | 1.1 |
|
| 1st | −4.5 | −1.3 | |
|
| 2nd | −4.8 | −1.2 | |
| CCL20 |
| 2nd | −5.3 | −3.5 |
| CD8A |
| 2nd | −3.4 | −1.1 |
| TLR4 |
| 2nd | −7.6 | −1.5 |
| IL6 |
| 1st | −2.0 | −1.2 |
Fold change (P<0.05).
Biological functions in the category “Disease and Disorder” of the transcripts differentially expressed by Eimeria infection.
| Infection |
| Biological Function Identified | P value | No. of Genes |
| 1st infection |
| Cancer | 6.75E-05 - 4.94E-02 | 32 |
| Gastrointestinal Disease | 2.34E-04 - 4.48E-02 | 15 | ||
| Genetic Disorder | 2.86E-04 - 3.20E-02 | 18 | ||
| Organismal Injury and Abnormalities | 2.23E-03 - 4.48E-02 | 5 | ||
| Connective Tissue Disorders | 5.08E-03 - 2.02E-02 | 4 | ||
|
| Connective Tissue Disorders | 2.19E-04 - 1.88E-02 | 4 | |
| Skeletal and Muscular Disorders | 2.19E-04 - 3.27E-02 | 13 | ||
| Developmental Disorder | 4.57E-04 - 3.89E-02 | 10 | ||
| Reproductive System Disease | 4.57E-04 - 3.27E-02 | 5 | ||
| Cancer | 7.64E-04 - 4.94E-02 | 32 | ||
|
| Genetic Disorder | 6.14E-14 - 6.85E-03 | 541 | |
| Cancer | 1.66E-10 - 6.80E-03 | 342 | ||
| Gastrointestinal Disease | 1.17E-06 - 6.80E-03 | 233 | ||
| Infection Mechanism | 2.14E-06 - 5.69E-03 | 130 | ||
| Infectious Disease | 2.14E-06 - 4.38E-03 | 138 | ||
| 2nd infection |
| Cancer | 1.44E-10 - 8.10E-03 | 353 |
| Genetic Disorder | 1.86E-10 - 7.38E-03 | 537 | ||
| Gastrointestinal Disease | 1.48E-08 - 7.38E-03 | 176 | ||
| Infectious Disease | 1.18E-07 - 6.81E-03 | 142 | ||
| Infection Mechanism | 1.25E-06 - 3.48E-03 | 143 | ||
|
| Cancer | 2.30E-11 - 1.18E-02 | 256 | |
| Infectious Disease | 3.17E-08 - 1.11E-02 | 112 | ||
| Genetic Disorder | 3.63E-08 - 1.18E-02 | 384 | ||
| Infection Mechanism | 6.12E-07 - 9.96E-03 | 115 | ||
| Gastrointestinal Disease | 2.36E-05 - 1.22E-02 | 127 | ||
|
| Genetic Disorder | 9.52E-13 - 1.24E-02 | 573 | |
| Cancer | 1.85E-11 - 1.46E-02 | 372 | ||
| Infectious Disease | 7.72E-08 - 1.45E-02 | 149 | ||
| Infection Mechanism | 1.10E-07 - 1.40E-02 | 154 | ||
| Gastrointestinal Disease | 9.37E-07 - 1.17E-02 | 255 |
Datasets were analyzed by BioFunction analysis using IPA software. Functions are listed in descending order of statistical significance with the most significant at the top of each Eimeria species grouping.
P values were calculated using the right-tailed Fisher's exact test.
Biological functions in the category “Physiological System Development and Function” of the transcripts differentially expressed by primary Eimeria infection.
|
| Biofucntion | P value | No. of Genes |
|
| Hepatic System Development and Function | 8.96E-04 - 4.48E-02 | 3 |
| Cell-mediated Immune Response | 5.08E-03 - 4.96E-02 | 4 | |
| Endocrine System Development and Function | 5.08E-03 - 4.96E-02 | 4 | |
| Hematological System Development and Function | 5.08E-03 - 4.96E-02 | 7 | |
| Hematopoiesis | 5.08E-03 - 4.96E-02 | 6 | |
|
| Tissue Morphology | 4.17E-04 - 4.63E-02 | 9 |
| Reproductive System Development and Function | 7.79E-04 - 4.18E-02 | 10 | |
| Hematological System Development and Function | 9.87E-04 - 4.63E-02 | 13 | |
| Renal and Urological System Development and Function | 1.67E-03 - 2.34E-02 | 6 | |
| Cell-mediated Immune Response | 1.70E-03 - 4.63E-02 | 8 | |
|
| Hematological System Development and Function | 2.41E-05 - 6.85E-03 | 126 |
| Hematopoiesis | 2.41E-05 - 2.82E-03 | 80 | |
| Cell-mediated Immune Response | 4.80E-05 - 2.69E-03 | 59 | |
| Connective Tissue Development and Function | 1.67E-04 - 6.85E-03 | 54 | |
| Digestive System Development and Function | 2.11E-04 - 5.20E-03 | 18 |
Datasets were analyzed by BioFunction analysis using IPA software. Functions are listed in descending order of statistical significance with the most significant at the top of each Eimeria species grouping.
P values were calculated using the right-tailed Fisher's exact test.
Figure 5Network analysis of differentially regulated transcripts.
The significantly modified signaling pathways (P<0.05) for the transcripts differentially expressed following primary and secondary infections by E. acervulina (EA), E. maxima (EM), or E. tenella (ET). A1; EA, A2; EM, and A3; ET.
Network analysis of the transcripts differentially expressed between 1–3 DPI and 4–6 DPI following primary Eimeria infection.
|
| Associated Network Functions | No. of Focus Genes |
|
| Genetic Disorder, Metabolic Disease, Amino Acid Metabolism | 26 |
| Lipid Metabolism, Small Molecule Biochemistry, Amino Acid Metabolism | 26 | |
| Lipid Metabolism, Small Molecule Biochemistry, Molecular Transport | 23 | |
| Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Cellular Compromise | 19 | |
| Cell Morphology, Cell-mediated Immune Response, Cellular Development | 16 | |
|
| Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | 22 |
| Cellular Development, Nervous System Development and Function, Cellular Assembly and Organization | 19 | |
| Lipid Metabolism, Small Molecule Biochemistry, Drug Metabolism | 15 | |
| Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | 8 | |
| Cellular Growth and Proliferation, Hematological System Development and Function, Inflammatory Response | 8 | |
|
| Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry | 27 |
| Connective Tissue Development and Function, Embryonic Development, Skeletal and Muscular System Development and Function | 24 | |
| Developmental Disorder, Neurological Disease, Genetic Disorder | 23 | |
| Cell Cycle, Carbohydrate Metabolism, Small Molecule Biochemistry | 21 | |
| Cell Cycle, Connective Tissue Development and Function, Cancer | 15 |
Datasets were analyzed by Network analysis using IPA software. Networks are listed in descending order of statistical significance with the most significant at the top of each Eimeria species grouping.